This contract involves the procurement of a recombinant, adsorbed vaccine against human papillomavirus (HPV) for the years 2025 to 2027. The buyer is the Croatian Institute of Public Health, and the total value of the contract is approximately 9,207,900 euros. Suppliers interested in this opportunit
Contract awarded. Originally published 12 months ago.
This contract involves the procurement of lyophilized tuberculosis vaccine (BCG) for the years 2025 to 2027. The buyer is the Croatian Institute of Public Health, and the total value of the contract is €78,000. Suppliers are invited to provide this essential health product to support public health i
This contract involves the procurement of a diphtheria and tetanus vaccine that is adsorbed and has a reduced antigen content. The procurement is intended for the years 2025 to 2027. Suppliers are invited to provide this vaccine to the Croatian Institute of Public Health, which is seeking to ensure
This contract opportunity is for the procurement of vaccines against Meningococcal Group B for the years 2025 to 2027. The buyer is the Croatian Institute of Public Health, and the total value of the contract is €76,220. Suppliers are invited to provide these essential vaccines to support public hea
This contract involves the procurement of combined vaccines for diphtheria, tetanus, pertussis (acellular), inactivated polio, Haemophilus influenzae type B, and hepatitis B. These vaccines are intended for primary vaccination and the first booster dose in the second year of life, covering the perio
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
